Advances in Autism Research. / Volume 1
This book represents one of the most up-to-date collections of articles on clinical practice and research in the field of Autism Spectrum Disorders (ASD). The scholars who contributed to this book are experts in their field, carrying out cutting edge research in prestigious institutes worldwide (e.g...
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2021 |
| Language: | English |
| Physical Description: | 1 electronic resource (400 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 08844nam-a2202797z--4500 | ||
|---|---|---|---|
| 001 | 993545505304498 | ||
| 005 | 20231214133433.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202201s2021 xx |||||o ||| 0|eng d | ||
| 035 | |a (CKB)5400000000043711 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/76388 | ||
| 035 | |a (EXLCZ)995400000000043711 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Narzisi, Antonio |4 edt | |
| 245 | 1 | 0 | |a Advances in Autism Research. |n Volume 1 |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (400 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | |a Open access |f Unrestricted online access |2 star | ||
| 520 | |a This book represents one of the most up-to-date collections of articles on clinical practice and research in the field of Autism Spectrum Disorders (ASD). The scholars who contributed to this book are experts in their field, carrying out cutting edge research in prestigious institutes worldwide (e.g., Harvard Medical School, University of California, MIND Institute, King’s College, Karolinska Institute, and many others). The book addressed many topics, including (1) The COVID-19 pandemic; (2) Epidemiology and prevalence; (3) Screening and early behavioral markers; (4) Diagnostic and phenotypic profile; (5) Treatment and intervention; (6) Etiopathogenesis (biomarkers, biology, and genetic, epigenetic, and risk factors); (7) Comorbidity; (8) Adulthood; and (9) Broader Autism Phenotype (BAP). This book testifies to the complexity of performing research in the field of ASD. The published contributions underline areas of progress and ongoing challenges in which more certain data is expected in the coming years. It would be desirable that experts, clinicians, researchers, and trainees could have the opportunity to read this updated text describing the challenging heterogeneity of Autism Spectrum Disorder. | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Neurosciences |2 bicssc | |
| 653 | |a autism spectrum disorder | ||
| 653 | |a infants | ||
| 653 | |a frontal EEG alpha asymmetry | ||
| 653 | |a early detection | ||
| 653 | |a autism spectrum disorders | ||
| 653 | |a toddlers | ||
| 653 | |a eye tracking | ||
| 653 | |a joint attention | ||
| 653 | |a longitudinal | ||
| 653 | |a regression | ||
| 653 | |a cytokines | ||
| 653 | |a PAI-1 | ||
| 653 | |a neuroinflammation | ||
| 653 | |a gastrointestinal | ||
| 653 | |a autism | ||
| 653 | |a literature review | ||
| 653 | |a comorbidity | ||
| 653 | |a early intervention | ||
| 653 | |a early intensive behavioral intervention | ||
| 653 | |a behavioral intervention | ||
| 653 | |a First Year Inventory | ||
| 653 | |a early screening | ||
| 653 | |a risk | ||
| 653 | |a cross-cultural generalisability | ||
| 653 | |a validity | ||
| 653 | |a preschool teachers | ||
| 653 | |a self-efficacy | ||
| 653 | |a knowledge | ||
| 653 | |a belief | ||
| 653 | |a skills | ||
| 653 | |a identify | ||
| 653 | |a autism spectrum disorder (ASD) | ||
| 653 | |a level 1 and level 2 screening tools | ||
| 653 | |a systematic review | ||
| 653 | |a COSMIN | ||
| 653 | |a PRISMA | ||
| 653 | |a screening | ||
| 653 | |a infection | ||
| 653 | |a prion | ||
| 653 | |a meta-analysis | ||
| 653 | |a motion analysis | ||
| 653 | |a video signal processing | ||
| 653 | |a neurodevelopmental disorders | ||
| 653 | |a infant screening | ||
| 653 | |a developmental language disorder | ||
| 653 | |a semantic features | ||
| 653 | |a word learning | ||
| 653 | |a central coherence | ||
| 653 | |a biomarker | ||
| 653 | |a p-cresol | ||
| 653 | |a mouse social behavior | ||
| 653 | |a dopamine | ||
| 653 | |a ASD | ||
| 653 | |a vision | ||
| 653 | |a proprioception | ||
| 653 | |a self-motion | ||
| 653 | |a immersive virtual reality | ||
| 653 | |a IVR | ||
| 653 | |a HMD | ||
| 653 | |a technology | ||
| 653 | |a persuasive text writing | ||
| 653 | |a perspective-taking | ||
| 653 | |a adolescence | ||
| 653 | |a intervention | ||
| 653 | |a sign language | ||
| 653 | |a imitation | ||
| 653 | |a cognition | ||
| 653 | |a language acquisition | ||
| 653 | |a prevalence estimate | ||
| 653 | |a predictors | ||
| 653 | |a surveillance review | ||
| 653 | |a Autism Spectrum Disorder (ASD) | ||
| 653 | |a early intensive intervention | ||
| 653 | |a developmental trajectories | ||
| 653 | |a moderators and mediators of intervention. | ||
| 653 | |a psychosis | ||
| 653 | |a schizophrenia | ||
| 653 | |a psychopathology | ||
| 653 | |a AQ | ||
| 653 | |a accuracy | ||
| 653 | |a attention to detail | ||
| 653 | |a self-awareness | ||
| 653 | |a insight | ||
| 653 | |a preconception risk factor | ||
| 653 | |a Gilles de la Tourette | ||
| 653 | |a obsession | ||
| 653 | |a compulsion | ||
| 653 | |a social behavior | ||
| 653 | |a social impairment | ||
| 653 | |a sensory profile | ||
| 653 | |a sensory responsiveness | ||
| 653 | |a feeding problems | ||
| 653 | |a short sensory profile (SSP) | ||
| 653 | |a sensory experience questionnaire (SEQ) | ||
| 653 | |a coronavirus | ||
| 653 | |a 2019-nCoV | ||
| 653 | |a neurodevelopment | ||
| 653 | |a child and adolescent psychiatry | ||
| 653 | |a mental health prevention | ||
| 653 | |a Asperger syndrome | ||
| 653 | |a adults | ||
| 653 | |a cerebrospinal fluid | ||
| 653 | |a antibodies | ||
| 653 | |a blood-brain barrier | ||
| 653 | |a GAD65 | ||
| 653 | |a Early Start Denver Model | ||
| 653 | |a high-risk infants | ||
| 653 | |a motor development | ||
| 653 | |a high-functioning autism | ||
| 653 | |a language | ||
| 653 | |a experience | ||
| 653 | |a communication | ||
| 653 | |a autonomic nervous system | ||
| 653 | |a wearable technologies | ||
| 653 | |a EEG | ||
| 653 | |a theory of mind | ||
| 653 | |a adults and adolescents | ||
| 653 | |a human figure drawings | ||
| 653 | |a Draw-a-Man | ||
| 653 | |a drawings maturity | ||
| 653 | |a social perception | ||
| 653 | |a ERP | ||
| 653 | |a reward response | ||
| 653 | |a RewP | ||
| 653 | |a sensitization | ||
| 653 | |a social skills intervention | ||
| 653 | |a PEERS® | ||
| 653 | |a adulthood | ||
| 653 | |a diagnosis | ||
| 653 | |a autistic traits | ||
| 653 | |a action observation | ||
| 653 | |a action prediction | ||
| 653 | |a context | ||
| 653 | |a priors | ||
| 653 | |a hypothalamus | ||
| 653 | |a amygdala | ||
| 653 | |a oxytocin | ||
| 653 | |a social cognition | ||
| 653 | |a social interaction | ||
| 653 | |a affiliative behavior | ||
| 653 | |a neuroimaging | ||
| 653 | |a COVID-19 | ||
| 653 | |a challenging behavior | ||
| 653 | |a dental care | ||
| 653 | |a oral health | ||
| 653 | |a medical procedures | ||
| 653 | |a ICT | ||
| 653 | |a wearable sensors | ||
| 653 | |a migration | ||
| 653 | |a Europe | ||
| 653 | |a health system | ||
| 653 | |a autism in adulthood | ||
| 653 | |a intellectual disability | ||
| 653 | |a regressive autism | ||
| 653 | |a epilepsy | ||
| 653 | |a challenging behaviors | ||
| 653 | |a empathy | ||
| 653 | |a executive functions | ||
| 653 | |a attention deficit and hyperactivity disorder | ||
| 653 | |a disruptive behavior disorders | ||
| 653 | |a alexithymia | ||
| 653 | |a anxiety | ||
| 653 | |a depression | ||
| 653 | |a TAS-20 | ||
| 653 | |a TSIA | ||
| 653 | |a parents | ||
| 653 | |a broader autism phenotype | ||
| 653 | |a autistic-like features | ||
| 653 | |a social-cognitive development | ||
| 653 | |a stereotypical behaviors | ||
| 653 | |a visual impairment | ||
| 653 | |a language profiles | ||
| 653 | |a grammatical comprehension | ||
| 653 | |a cannabinoids | ||
| 653 | |a cannabidiol | ||
| 653 | |a cannabidivarin | ||
| 653 | |a THC | ||
| 653 | |a problem behaviors | ||
| 653 | |a sleep | ||
| 653 | |a hyperactivity | ||
| 653 | |a side effects | ||
| 653 | |a motor performance skills | ||
| 653 | |a Gulf | ||
| 653 | |a BOT-2 | ||
| 653 | |a machine learning | ||
| 653 | |a employment | ||
| 653 | |a telehealth | ||
| 653 | |a ABA | ||
| 653 | |a RCT | ||
| 653 | |a cortisol | ||
| 653 | |a group activity | ||
| 653 | |a stress | ||
| 653 | |a art | ||
| 653 | |a assessment | ||
| 653 | |a sensorimotor integration | ||
| 653 | |a postural balance | ||
| 653 | |a false positive report probability (FPRP) | ||
| 653 | |a Bayesian false-discovery probability (BFDP) | ||
| 653 | |a Genome-Wide Association Studies (GWAS) | ||
| 653 | |a microbiome | ||
| 653 | |a metabolomics | ||
| 653 | |a study design | ||
| 653 | |a biomarker discovery | ||
| 653 | |a precise medicine | ||
| 653 | |a bipolar disorder | ||
| 653 | |a suicidal ideation | ||
| 653 | |a suicidal attempts | ||
| 776 | |z 3-0365-0162-2 | ||
| 776 | |z 3-0365-0163-0 | ||
| 700 | 1 | |a Narzisi, Antonio |4 oth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:53:58 Europe/Vienna |f system |c marc21 |a 2022-04-04 09:22:53 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337934210004498&Force_direct=true |Z 5337934210004498 |b Available |8 5337934210004498 | ||